Global Tuberculosis Report -- 2012.pdf

More documents

Recommendations

Info

INCIDENCE (INCLUDING HIV) INCIDENCE HIV-POSITIVE NOTIFIED NEW AND RELAPSE CASE DETECTIONYEARPOPULATION(MILLIONS)NUMBER(THOUSANDS)RATE aNUMBER(THOUSANDS)RATE a NUMBER RATE a PERCENTMicronesia 1990 < 1 0.36 (0.100–0.800) 379 (104–827) 367 381 100 (46–370)(Federated 1995 < 1 0.35 (0.200–0.540) 325 (185–505) 172 160 49 (32–87)States of) 2000 < 1 0.3 (0.210–0.400) 279 (200–371) 91 85 30 (23–43)2005 < 1 0.26 (0.170–0.370) 240 (158–338) 98 90 37 (26–57)2009 < 1 0.23 (0.110–0.400) 212 (101–365) 148 134 63 (37–130)2010 < 1 0.23 (0.098–0.410) 206 (89–371) 160 144 70 (39–160)2011 < 1 0.22 (0.096–0.400) 200 (86–360) 148 133 66 (37–150)Mongolia 1990 2 8.9 (7.6–10) 405 (345–470) 0 (0–
YEARPOPULATION(MILLIONS)INCIDENCE (INCLUDING HIV) INCIDENCE HIV-POSITIVE NOTIFIED NEW AND RELAPSE CASE DETECTIONNUMBER(THOUSANDS)RATE aNUMBER(THOUSANDS)RATE a NUMBER RATE a PERCENTTuvalu 1990 < 1 0.048 (0.031–0.069) 536 (347–766) 23 255 48 (33–74)1995 < 1 0.04 (0.017–0.074) 437 (181–805) 36 390 89 (48–220)2000 < 1 0.034 (0.022–0.048) 357 (231–510) 16 170 48 (33–74)2005 < 1 0.028 (0.019–0.039) 291 (198–402) 12 124 43 (31–63)2009 < 1 0.024 (0.012–0.041) 247 (121–418) 18 184 74 (44–150)2010 < 1 0.023 (0.013–0.036) 237 (135–368) 14 142 60 (39–110)2011 < 1 0.022 (0.013–0.035) 228 (130–353) 12 122 53 (35–94)Vanuatu 1990 < 1 0.19 (0.150–0.230) 127 (103–154) 140 95 75 (62–93)1995 < 1 0.11 (0.085–0.130) 63 (51–76) 79 47 75 (62–93)2000 < 1 0.2 (0.160–0.250) 110 (89–132) 152 82 75 (62–93)2005 < 1 0.17 (0.140–0.210) 83 (68–99) 76 36 44 (36–53)2009 < 1 0.17 (0.140–0.200) 72 (59–86) 0.05 (0.036–0.067) 22 (15–29) 134 57 80 (67–97)2010 < 1 0.17 (0.140–0.200) 69 (57–83) 116 48 70 (58–85)2011 < 1 0.16 (0.140–0.200) 67 (55–80) 110 45 67 (56–81)Viet Nam 1990 67 140 (100–170) 204 (155–261)
Page 2 and 3:
GLOBALTUBERCULOSISREPORT2012
Page 4 and 5:
ContentsAbbreviationsivAcknowledgem
Page 6 and 7:
AcknowledgementsThis report on glob
Page 8 and 9:
WHO Western Pacific RegionShalala A
Page 10 and 11:
Executive SummaryThe World Health O
Page 12 and 13:
CHAPTER 1IntroductionBOX 1.1Basic f
Page 14 and 15:
TABLE 1.1 Targets for the scale-up
Page 16 and 17:
TABLE 1.2 Reporting of data in the
Page 18 and 19:
BOX 2.1Uncertainty in estimates of
Page 20 and 21:
TABLE 2.2 Estimated burden of disea
Page 22 and 23:
FIGURE 2.5 Estimated TB incidence r
Page 24 and 25:
FIGURE B2.2.1Reporting of notificat
Page 26 and 27:
FIGURE 2.8Estimated TB incidence ra
Page 28 and 29:
FIGURE 2.11 Countries (in blue) for
Page 30 and 31:
FIGURE 2.12 Trends in estimated TB
Page 32 and 33:
● producing and widely disseminat
Page 34 and 35:
FIGURE 2.16 Progress in global cove
Page 36 and 37:
BOX 2.6Efforts by the Task Force to
Page 38 and 39:
CHAPTER 3TB case notificationsand t
Page 40 and 41:
BOX 3.1 1Definitions of TB casesDef
Page 42 and 43:
TABLE 3.3 Contribution of public-pr
Page 44 and 45:
BOX 3.4Integrating community-based
Page 46 and 47:
TABLE 3.4 Estimates of the case det
Page 48 and 49:
TABLE 3.5 Treatment success for new
Page 50 and 51:
CHAPTER 4Drug-resistant TBKEY FACTS
Page 52 and 53:
FIGURE 4.2 Percentage of new TB cas
Page 54 and 55:
BOX 4.1Frequencies of resistance to
Page 56 and 57:
FIGURE 4.6 Number of MDR-TB cases e
Page 58 and 59:
FIGURE 4.7Notified cases of MDR-TB
Page 60 and 61:
egimens globally, providing more su
Page 62 and 63:
5.1 Funding for TB care and control
Page 64 and 65:
TABLE 5.2 NTP budgets, available fu
Page 66 and 67:
FIGURE 5.5Trends in domestic and do
Page 68 and 69:
FIGURE 5.6Domestic funding as a per
Page 70 and 71:
FIGURE 5.8Cost per TB patient succe
Page 72 and 73:
FIGURE 5.10 Total cost and unit cos
Page 74 and 75:
● The 14 countries not included i
Page 76 and 77:
on public health by an external Exp
Page 78 and 79:
evised as a result of the introduct
Page 80 and 81:
TABLE 6.2 Incorporation of WHO poli
Page 82 and 83:
FIGURE 6.3The Supranational Referen
Page 84 and 85:
of TB disease by 65%, irrespective
Page 86 and 87:
FIGURE 7.3Percentage of TB patients
Page 88 and 89:
BOX 7.1Accelerating progress in pro
Page 90 and 91:
TABLE 7.2 Assumptions used to estim
Page 92 and 93:
FIGURE 8.1 The development pipeline
Page 94 and 95:
sputum specimens and TB isolates fr
Page 96 and 97:
cal trial sites and building labora
Page 98:
new TB vaccine candidate. A Phase I
Page 102 and 103:
This annex explains the methods tha
Page 104 and 105:
2011. On average, 15 data points we
Page 106 and 107:
may suffer from biases. These biase
Page 108 and 109:
TABLE A1.3Parameter estimates used
Page 110 and 111:
5. Estimates of TB prevalence, 1990
Page 112:
the Republic of Moldova, Romania, t
Page 116 and 117:
AFGHANISTANPopulation 2011 32 milli
Page 118 and 119:
BRAZILPopulation 2011 197 millionHI
Page 120 and 121:
CHINAPopulation 2011 1 348 millionH
Page 122 and 123:
ETHIOPIAPopulation 2011 85 millionH
Page 124 and 125:
INDONESIAPopulation 2011 242 millio
Page 126 and 127:
MOZAMBIQUEPopulation 2011 24 millio
Page 128 and 129:
NIGERIAPopulation 2011 162 millionH
Page 130 and 131:
PHILIPPINESPopulation 2011 95 milli
Page 132 and 133:
SOUTH AFRICAPopulation 2011 50 mill
Page 134 and 135:
UGANDAPopulation 2011 35 millionHIG
Page 136 and 137:
VIET NAMPopulation 2011 89 millionH
Page 138:
ANNEX 3Regional profiles
Page 141 and 142:
WHO REGION OF THE AMERICASPopulatio
Page 143 and 144:
WHO EUROPEAN REGIONPopulation 2011
Page 145 and 146:
WHO WESTERN PACIFIC REGIONPopulatio
Page 148 and 149:
SUMMARY BY WHO REGIONTable A4.1 Est
Page 150 and 151:
MORTALITY (EXCLUDING HIV) PREVALENC
Page 152 and 153:
NEW AND RELAPSENOTIFICATION RATE aY
Page 154 and 155:
-% OF TB PATIENTS WITHKNOWN HIV STA
Page 156 and 157:
AFRICAN REGIONTable A4.1 Estimates
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
INCIDENCE (INCLUDING HIV) INCIDENCE
Page 164 and 165:
NEW AND RELAPSENOTIFICATION RATE aY
Page 166 and 167:
NEW AND RELAPSENOTIFICATION RATE a1
Page 168 and 169:
TREATMENT SUCCESS (%) a1995-2010YEA
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
YEARTOTALCONFIRMEDCASES OFMDR-TB aE
Page 178 and 179:
MALEYEAR 0-14 15-24 25-34 35-44 45-
Page 180 and 181:
REGION OF THE AMERICASTable A4.1 Es
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
% OF COHORTTREATMENT SUCCESS (%) a1
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
YEARTOTALCONFIRMEDCASES OFMDR-TB aE
Page 202 and 203:
MALEFEMALEYEAR 0-14 15-24 25-34 35-
Page 204 and 205:
EASTERN MEDITERRANEAN REGIONTable A
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217: -% OF TB PATIENTS WITHKNOWN HIV STA
Page 218 and 219: MALEFEMALEYEAR 0-14 15-24 25-34 35-
Page 220 and 221: EUROPEAN REGIONTable A4.1 Estimates
Page 222 and 223: MORTALITY (EXCLUDING HIV) PREVALENC
Page 226 and 227: INCIDENCE (INCLUDING HIV) INCIDENCE
Page 228 and 229: INCIDENCE (INCLUDING HIV) INCIDENCE
Page 230 and 231: NEW AND RELAPSENOTIFICATION RATE a1
Page 234 and 235: % OF COHORTTREATMENT SUCCESS (%) a1
Page 242 and 243: YEARTOTALCONFIRMEDCASES OFMDR-TB aE
Page 248 and 249: SOUTH-EAST ASIA REGIONTable A4.1 Es
Page 258: SMEAR LABS % OF SMEARPER 100K LABS
Page 261 and 262: Estimates of mortality, prevalence
Page 263 and 264: YEARPOPULATION(MILLIONS)MORTALITY (
Page 265: YEARPOPULATION(MILLIONS)INCIDENCE (
Page 271 and 272: TREATMENT SUCCESS (%) a1995-2010YEA
Page 273 and 274: TREATMENT SUCCESS (%) a1995-2010YEA
Page 281 and 282: SMEAR LABS % OF SMEARPER 100K LABS
show all

Global Tuberculosis Report -- 2012.pdf

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?